In 2024, biopharmaceutical company Sanofi spent approximately 7.4 billion euros on research and development. Sanofi’s R&D expenditures have increased over most of the provided period, with exceptions being the years 2020 and 2023.
The French pharmaceutical giant
Sanofi Société Anonyme (or Sanofi S.A.), headquartered in Paris, France, is active in more than one hundred countries worldwide, with a global workforce of around 85 thousand people in 2024. The company generates most of its revenue from its biopharma segment, while over five billion euros were earned through the company’s consumer healthcare segment (only until 2023). Sanofi is also a global leader in vaccines. In 2024, some 2.6 billion euros were generated through influenza vaccines.
Clinical trials
A clinical trial or study is conducted to uncover whether a particular compound is efficient and safe to use for the treatment of people. It is a lengthy process that can take several years. Such trials are also necessary to get a vaccine or a drug approved for marketing purposes.
Advertisement
Advertisement
Research and development expenditure of Sanofi from 2008 to 2024
(in million euros)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sanofi, & Company filings. (February 17, 2025). Research and development expenditure of Sanofi from 2008 to 2024 (in million euros) [Graph]. In Statista. Retrieved June 26, 2025, from https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi, und Company filings. "Research and development expenditure of Sanofi from 2008 to 2024 (in million euros)." Chart. February 17, 2025. Statista. Accessed June 26, 2025. https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi, Company filings. (2025). Research and development expenditure of Sanofi from 2008 to 2024 (in million euros). Statista. Statista Inc.. Accessed: June 26, 2025. https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi, and Company filings. "Research and Development Expenditure of Sanofi from 2008 to 2024 (in Million Euros)." Statista, Statista Inc., 17 Feb 2025, https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi & Company filings, Research and development expenditure of Sanofi from 2008 to 2024 (in million euros) Statista, https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/ (last visited June 26, 2025)
Research and development expenditure of Sanofi from 2008 to 2024 (in million euros) [Graph], Sanofi, & Company filings, February 17, 2025. [Online]. Available: https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
